Reference
1 ) Goodwin FK, Jamison KKR. Manic-Depressive Illness:
Bipolar Disorders and Recurrent Depression. Second
Edition.: Oxford University Press; 2007.
2 ) Hayes JF, Miles J, Walters K, King M, Osborn DP: A
systematic review and meta-analysis of premature
mortality in bipolar affective disorder. Acta Psychiatr
Scand. 2015; 131: 417-25.
3 ) Ishikawa H, Tachimori H, Takeshima T, et al: Prevalence, treatment, and the correlates of common mental
disorders in the mid 2010’s in Japan: The results of the
world mental health Japan 2nd survey. J Affect Disord.
2018; 241: 554-62.
4 ) Ishikawa H, Kawakami N, Kessler RC, World Mental
Health Japan Survey C: Lifetime and 12-month prevalence, severity and unmet need for treatment of
common mental disorders in Japan: results from the
final dataset of World Mental Health Japan Survey.
Epidemiol Psychiatr Sci. 2016; 25: 217-29.
5 ) Kato T, Baba K, Guo W, Chen Y, Nosaka T: Impact of
bipolar disorder on health-related quality of life and
work productivity: Estimates from the national health
and wellness survey in Japan. J Affect Disord. 2021;
295: 203-14.
6 ) Angst J, Azorin JM, Bowden CL, et al: Prevalence and
characteristics of undiagnosed bipolar disorders in
patients with a major depressive episode: the BRIDGE
study. Arch Gen Psychiatry. 2011; 68: 791-8.
7 ) American_Psychiatric_Association. Diagnostic and
Statistical Manual of Mental Disorders: DSM-5: Amer
Psychiatric Pub Inc; 2013.
8 ) Freedman R, Lewis DA, Michels R, et al: The initial
field trials of DSM-5: new blooms and old thorns. Am
J Psychiatry. 2013; 170: 1-5.
9 ) Ratheesh A, Davey C, Hetrick S, et al: A systematic
review and meta-analysis of prospective transition from
major depression to bipolar disorder. Acta Psychiatr
Scand. 2017; 135: 273-84.
10.Kato T, Sakai N, Watanabe Y, Nomura S: Possibility of
over-diagnosis of bipolar disorder due to near-infrared
spectroscopy. Psychiatry Clin Neurosci. 2017; 71: 843.
11) Kato T: Current understanding of bipolar disorder:
Toward integration of biological basis and treatment24Kato T: Bipolar Disorder
strategies. Psychiatry Clin Neurosci. 2019; 73: 526-40.
12) Cavanagh JT, Van Beck M, Muir W, Blackwood DH:
Case-control study of neurocognitive function in
euthymic patients with bipolar disorder: an association
with mania. Br J Psychiatry. 2002; 180: 320-6.
13) Kanba S, Kato T, Terao T, Yamada K: Guideline for
treatment of bipolar disorder by the Japanese Society
of Mood Disorders, 2012. Psychiatry Clin Neurosci.
2013; 67: 285-300.
14) Kato T, Ishigooka J, Miyajima M, et al: Double-blind,
placebo-controlled study of lurasidone monotherapy
for the treatment of bipolar I depression. Psychiatry
Clin Neurosci. 2020; 74: 635-44.
15) Calabrese JR, Sanchez R, Jin N, et al: Efficacy and
Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A DoubleBlind, Placebo-Controlled, 52-Week Randomized Withdrawal Study. J Clin Psychiatry. 2017; 78: 324-31.
16) Patorno E, Huybrechts KF, Bateman BT, et al: Lithium
Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017; 376: 2245-54.
17) Miklowitz DJ, Efthimiou O, Furukawa TA, et al: Adjunctive Psychotherapy for Bipolar Disorder: A Systematic
Review and Component Network Meta-analysis. JAMA
Psychiatry. 2021; 78: 141-50.
18) Kato T: Molecular genetics of bipolar disorder and
depression. Psychiatry Clin Neurosci. 2007; 61: 3-19.
19) Aldinger F, Schulze TG: Environmental factors, life
events, and trauma in the course of bipolar disorder.
Psychiatry Clin Neurosci. 2017; 71: 6-17.
20) Ikeda M, Saito T, Kondo K, Iwata N: Genome-wide
association studies of bipolar disorder: A systematic
review of recent findings and their clinical implications. Psychiatry Clin Neurosci. 2018; 72: 52-63.
21) Mullins N, Forstner AJ, O’Connell KS, et al: Genomewide association study of more than 40,000 bipolar
disorder cases provides new insights into the underlying biology. Nat Genet. 2021; 53: 817-29.
22) Ikeda M, Takahashi A, Kamatani Y, et al: A genomewide association study identifies two novel susceptibility loci and trans population polygenicity associated
with bipolar disorder. Mol Psychiatry. 2017.
23) Nishioka M, Kazuno AA, Nakamura T, et al: Systematic analysis of exonic germline and postzygotic de
novo mutations in bipolar disorder. Nat Commun. 2021;
12: 3750.
24) Kato T: Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond. Schizophr
Res. 2017; 187: 62-6.
25) Kasahara T, Takata A, Kato TM, et al: Depression-like
episodes in mice harboring mtDNA deletions in paraventricular thalamus. Mol Psychiatry. 2016; 21: 39-48.
26) Hsu DT, Kirouac GJ, Zubieta JK, Bhatnagar S: Contributions of the paraventricular thalamic nucleus in the
regulation of stress, motivation, and mood. Front
Behav Neurosci. 2014; 8: 73.
27) Kato TM, Kubota-Sakashita M, Fujimori-Tonou N,
et al: Ant1 mutant mice bridge the mitochondrial and
serotonergic dysfunctions in bipolar disorder. Mol
Psychiatry. 2018; 23: 2039-49.
28) Mertens J, Wang QW, Kim Y, et al: Differential responses
to lithium in hyperexcitable neurons from patients
with bipolar disorder. Nature. 2015; 527: 95-9.
29) Horisawa T, Ishiyama T, Ono M, Ishibashi T, Taiji M:
Binding of lurasidone, a novel antipsychotic, to rat
5-HT7 receptor: analysis by [3H]SB-269970 autoradiography. Prog Neuropsychopharmacol Biol Psychiatry.
2013; 40: 132-7.
30) Sharpley AL, Williams C, Holder AA, et al: A phase 2a
randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005)
as a novel treatment for mania or hypomania. Psychopharmacology (Berl). 2020; 237: 3773-82.
Bipolar Disorders Reference
未分類